ral Guanine Nucleotide Exchange Factor
|
D12.644.360.325.300.600 |
|
Guanine Nucleotide Exchange Factors
|
D12.644.360.325.300 |
|
Artesunate
|
D02.455.849.765.211.500 |
|
Artemisinins
|
D02.455.849.765.211 |
|
Rubus
|
B01.650.940.800.575.912.250.859.937.500.764 |
|
Rituximab
|
D12.776.124.790.651.114.224.075.785 |
|
Antibodies, Monoclonal, Murine-Derived
|
D12.776.124.790.651.114.224.075 |
|
Dermatitis, Atopic
|
C17.800.174.193 |
|
Contact Lenses
|
E07.632.500.276 |
|
Lenses
|
E07.632.500 |
|
Streptococcus gallolyticus
|
B03.510.550.737.872.243 |
|
Streptococcus
|
B03.510.550.737.872 |
|
1-Naphthylamine
|
D015057 |
[A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.
] |
1-Naphthylisothiocyanate
|
D015058 |
[A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.
] |
1-Carboxyglutamic Acid
|
D015055 |
[Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.
] |
1-Methyl-3-isobutylxanthine
|
D015056 |
[A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
] |
3-Oxoacyl-(Acyl-Carrier-Protein) Synthase
|
D08.811.913.050.622 |
|
Acyltransferases
|
D08.811.913.050 |
|
Sand
|
D20.721.750 |
|
Soil
|
D20.721 |
|